Arcturus Therapeutics Holdings Inc (ARCT)
26.98
-0.95
(-3.40%)
USD |
NASDAQ |
Apr 24, 16:00
26.98
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Total Liabilities (Quarterly): 150.89M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 150.89M |
| September 30, 2023 | 177.59M |
| June 30, 2023 | 145.47M |
| March 31, 2023 | 141.62M |
| December 31, 2022 | 180.08M |
| September 30, 2022 | 147.96M |
| June 30, 2022 | 166.30M |
| March 31, 2022 | 157.24M |
| December 31, 2021 | 164.60M |
| September 30, 2021 | 175.41M |
| June 30, 2021 | 143.16M |
| March 31, 2021 | 128.86M |
| December 31, 2020 | 79.90M |
| September 30, 2020 | 60.89M |
| June 30, 2020 | 56.51M |
| March 31, 2020 | 55.12M |
| December 31, 2019 | 56.35M |
| September 30, 2019 | 51.32M |
| June 30, 2019 | 49.32M |
| March 31, 2019 | 38.06M |
| December 31, 2018 | 30.56M |
| Date | Value |
|---|---|
| September 30, 2018 | 22.96M |
| June 30, 2018 | 26.53M |
| December 31, 2017 | 18.23M |
| September 30, 2017 | 2.296M |
| June 30, 2017 | 1.657M |
| March 31, 2017 | 2.19M |
| December 31, 2016 | 12.16M |
| September 30, 2016 | 3.295M |
| June 30, 2016 | 2.907M |
| March 31, 2016 | 2.11M |
| December 31, 2015 | 2.352M |
| September 30, 2015 | 2.564M |
| June 30, 2015 | 2.864M |
| December 31, 2014 | 2.375M |
| September 30, 2014 | 4.905M |
| June 30, 2014 | 4.753M |
| March 31, 2014 | 3.346M |
| December 31, 2013 | 1.636M |
| September 30, 2013 | 1.281M |
| June 30, 2013 | 0.343M |
| December 31, 2012 | 0.768M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
49.32M
Minimum
Jun 2019
180.08M
Maximum
Dec 2022
120.45M
Average
143.16M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Electromed Inc | 6.622M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 429.40M |
| Shareholders Equity (Quarterly) | 278.51M |
| Current Ratio | 4.715 |
| Net Debt Paydown Yield | 1.41% |